3.53
Finanzdaten der Atea Pharmaceuticals Inc-Aktie (AVIR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
|
5.90%
41.34
|
39.04 | 39.03 | 37.20 | 46.92 |
Depreciation and Amortization |
0.00%
0.104
|
0.104 | 0.104 | 0.104 | 0.104 |
Operating Income/Loss |
5.90%
-41.34
|
-39.04 | -39.03 | -37.20 | -46.92 |
Income/Loss From Continuing Operations Before Tax |
8.47%
-36.95
|
-34.07 | -33.32 | -30.93 | -40.28 |
Income Tax Expense/Benefit |
1.97%
0.207
|
0.203 | 0.225 | 0.226 | 0.243 |
Income/Loss From Continuing Operations After Tax |
8.43%
-37.16
|
-34.27 | -33.54 | -31.15 | -40.52 |
|
8.43%
-37.16
|
-34.27 | -33.54 | -31.15 | -40.52 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.66%
83.75
|
85.16 | 0.0666 | 84.42 | 84.25 |
Diluted Average Shares |
1.66%
83.75
|
85.16 | 0.0666 | 84.42 | 84.25 |
Basic Earnings Per Share |
10.00%
-0.44
|
-0.40 | -0.40 | -0.37 | -0.48 |
Diluted Earnings Per Share |
10.00%
-0.44
|
-0.40 | -0.40 | -0.37 | -0.48 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):